haloxyfop-P as methyl(520g/L) - rizultati

Norveġja - Norveġiż - Statens legemiddelverk

cipralex 10 mg

orifarm as - escitalopramoksalat - tablett, filmdrasjert - 10 mg

Norveġja - Norveġiż - Statens legemiddelverk

cipramil 20 mg

orifarm as - citalopramhydrobromid - tablett, filmdrasjert - 20 mg

Unjoni Ewropea - Norveġiż - EMA (European Medicines Agency)

zejula

glaxosmithkline (ireland) limited - niraparib (tosilate monohydrate) - fallopian tube neoplasms; peritoneal neoplasms; ovarian neoplasms - antineoplastiske midler - zejula is indicated: , as monotherapy for the maintenance treatment of adult patients with advanced epithelial (figo stages iii and iv) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. , as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy.

Norveġja - Norveġiż - Statens legemiddelverk

hytacand 8 mg / 12.5 mg

orifarm as - kandesartancileksetil / hydroklortiazid - tablett - 8 mg / 12.5 mg

Norveġja - Norveġiż - Statens legemiddelverk

cozaar comp 100 mg / 12.5 mg

orifarm as - losartankalium / hydroklortiazid - tablett, filmdrasjert - 100 mg / 12.5 mg

Norveġja - Norveġiż - Statens legemiddelverk

cozaar comp 50 mg / 12.5 mg

orifarm as - losartankalium / hydroklortiazid - tablett, filmdrasjert - 50 mg / 12.5 mg

Norveġja - Norveġiż - Statens legemiddelverk

cipralex 20 mg

orifarm as - escitalopramoksalat - tablett, filmdrasjert - 20 mg